Navigation Links
Newly Published Article Details How PGS Techniques Directly Effect Successful Pregnancy Outcomes
Date:5/27/2009

Fertility and Sterility Publishes Article Underscoring Importance of PGD Technique and Method

LIVINGSTON, N.J., May 27 /PRNewswire/ -- A group of fertility experts, who pioneered the development of Preimplantation Genetic Screening (PGS), are sharing the step-by-step best practices and explaining what errors can be made along the way.

The article, published in the latest edition of Fertility and Sterility, details when PGS should be used, emphasizes proper embryo biopsy technique and reveals the most common errors made with the ultimate goal of educating clinics, embryologists and other experts to improve pregnancy outcomes.

When done correctly, PGS can be used to improve the success of in vitro fertilization (IVF) for women of advanced maternal age and recurrent pregnancy loss. Research shows that many times IVF fails because a majority of embryos created in vitro are chromosomally abnormal. When done correctly, PGS screens the most important chromosomes in terms of preimplantation aneuploidy (22, 16, 21 and 15), improving implantation rates.

Dr. Santiago Munne, of Reprogenetics, LLC. in Livingston, NJ, who has performed close to 15 thousand PGS cases, says this article is a must-read in any center that performs PGS.

"This article is the result of years of research and refining the PGS technique that have allowed us to achieve the success rates that we have seen," says Dr. Munne. "The techniques and technology described in this paper are required in order to improve successful pregnancy outcomes."

The article gives explicit detail about each step of the PGS process including opening the zona pellucida, removing the cell, cell fixation, how many chromosomes should be analyzed, and error rate criteria. As previous studies have shown, improper technique as well as inexperienced technicians or inadequate training, can lead to extremely increased error rates and ultimately IVF failure.

"The problem is, entire studies have been conducted where proper protocol has not been followed, causing doctors to come to conclusions that are often inaccurate," states Munne. "It is clear that not all laboratories can reproduce positive results. In those laboratories, PGS should be considered experimental."

To find a clinic that meets the protocol as published in Fertility and Sterility, requirements for preimplantation genetic diagnosis, contact client services at Reprogenetics, LLC - clientservices@reprogenetics.com or 973-436-5004.

    Contact:    Deborah Sittig
                Green Room PR
                Office: 973-263-8585 ext. 22
                Cell: 908-377-8700
                Deborah@greenroompr.com


'/>"/>
SOURCE Reprogenetics, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density
2. Schering-Ploughs Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
3. BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
4. Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
5. Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma
6. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
7. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
8. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
9. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
10. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
11. Newly Approved HIV Drug Shows Great Promise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... , Feb. 19, 2017  nThrive™, an ... cycle portfolio and thought leadership at the 2017 ... a category leader award from KLAS. ... discussion focused on how market trends shape the ... particularly a sophisticated, comprehensive Patient Access solution. The ...
(Date:2/19/2017)... SAN FRANCISCO and ORLANDO, Fla. ... (Nasdaq: NKTR ) today announced that positive ... NKTR-214, in patients with renal cell carcinoma (RCC) were ... immuno-stimulatory therapy designed to expand specific cancer-fighting T cells ... tumor micro-environment and increase expression of PD-1 on these ...
(Date:2/18/2017)... -- Research and Markets has announced the addition of the ... ... comprehensive analytics for the US, Canada , ... , Latin America , and Rest of World. Annual ... a six-year historic analysis is provided for these markets. Market data and ...
Breaking Medicine Technology:
(Date:2/20/2017)... ... February 20, 2017 , ... Today, Illuma Care Connections, a ... during the 2017 Annual HIMSS Conference & Exhibition in Orlando, Florida, ... and integrating eye care into mainstream healthcare delivery is powered by Secure ...
(Date:2/19/2017)... ... 19, 2017 , ... ProBrand Glitch is a set of 30 glitch distortion logo reveals made ... reveal any logo with a glitch reveal in just a few clicks of a mouse. ... animation of each preset. Use these presets to add a uniquely animated logo to any ...
(Date:2/18/2017)... Waltham, Massachusetts (PRWEB) , ... February 17, 2017 ... ... be the leading source of disruptive innovation in the industry, according to the ... Insights Reports are based on surveys of the NEJM Catalyst Insights Council, a ...
(Date:2/18/2017)... CA (PRWEB) , ... February 18, 2017 , ... ... paragraph presets. Use Pixel Film Studios ’ ProParagraph Fashion Volume 2 ... and so many other applications. Users can pick and choose from hand-crafted ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... on foundational and sustainable systems change designed to further positively impact the health ... Board of Trustees has long considered it our duty to seriously consider releasing ...
Breaking Medicine News(10 mins):